JP2001525668A5 - - Google Patents

Download PDF

Info

Publication number
JP2001525668A5
JP2001525668A5 JP1998548477A JP54847798A JP2001525668A5 JP 2001525668 A5 JP2001525668 A5 JP 2001525668A5 JP 1998548477 A JP1998548477 A JP 1998548477A JP 54847798 A JP54847798 A JP 54847798A JP 2001525668 A5 JP2001525668 A5 JP 2001525668A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998548477A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001525668A (ja
JP4480800B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/009288 external-priority patent/WO1998050527A1/en
Publication of JP2001525668A publication Critical patent/JP2001525668A/ja
Publication of JP2001525668A5 publication Critical patent/JP2001525668A5/ja
Application granted granted Critical
Publication of JP4480800B2 publication Critical patent/JP4480800B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54847798A 1997-05-08 1998-05-07 活性化t細胞および抗原パルス標識した抗原提示細胞を生成する方法 Expired - Fee Related JP4480800B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4594997P 1997-05-08 1997-05-08
US60/045,949 1997-05-08
PCT/US1998/009288 WO1998050527A1 (en) 1997-05-08 1998-05-07 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells

Publications (3)

Publication Number Publication Date
JP2001525668A JP2001525668A (ja) 2001-12-11
JP2001525668A5 true JP2001525668A5 (cg-RX-API-DMAC10.html) 2005-12-02
JP4480800B2 JP4480800B2 (ja) 2010-06-16

Family

ID=21940709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54847798A Expired - Fee Related JP4480800B2 (ja) 1997-05-08 1998-05-07 活性化t細胞および抗原パルス標識した抗原提示細胞を生成する方法

Country Status (10)

Country Link
US (1) US6600012B1 (cg-RX-API-DMAC10.html)
EP (3) EP0986636B1 (cg-RX-API-DMAC10.html)
JP (1) JP4480800B2 (cg-RX-API-DMAC10.html)
AT (2) ATE394474T1 (cg-RX-API-DMAC10.html)
AU (1) AU727863B2 (cg-RX-API-DMAC10.html)
CA (1) CA2289742C (cg-RX-API-DMAC10.html)
DE (2) DE69839443D1 (cg-RX-API-DMAC10.html)
DK (1) DK1634949T3 (cg-RX-API-DMAC10.html)
ES (1) ES2357960T3 (cg-RX-API-DMAC10.html)
WO (1) WO1998050527A1 (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906744A1 (de) * 1999-02-18 2000-08-24 Martin Roecken Verfahren zur Herstellung antitumoraler Th1-Zellen
CA2368967A1 (en) * 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine
DE19917195B4 (de) * 1999-04-16 2006-09-28 Immatics Biotechnologies Gmbh Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor
WO2001018035A2 (en) * 1999-09-08 2001-03-15 Transgene S.A. Muc-1 derived peptides
GB9921337D0 (en) 1999-09-09 1999-11-10 Axis Genetics Plc Modified plant viruses
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
ES2424131T3 (es) * 2001-03-27 2013-09-27 Oncothyreon Inc. Vacuna para modular respuestas inmunitarias entre T1 y T2
US7282222B2 (en) 2002-03-15 2007-10-16 The United States Of America As Represented By The Department Of Veterans Affairs Methods and compositions for directing cells to target organs
EP1572918B1 (en) * 2002-04-15 2011-10-19 Oncothyreon Inc. Synthetic glyco-lipo-peptides as vaccines
US20060142546A1 (en) * 2002-09-05 2006-06-29 Franz-Georg Hanisch Immunogenic muc1 glycopeptides
CA2501527A1 (en) * 2002-10-10 2004-04-22 Catherine A. Phillips Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
US20050045205A1 (en) * 2003-08-29 2005-03-03 Stach Steven R. Apparatus and method for cleaning printed circuit boards
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
JP5060134B2 (ja) * 2003-12-12 2012-10-31 ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ・アズ リプレゼンテッド バイ ザ セクレタリー・デパートメント オブ ヘルス アンド ヒューマン サービシーズ ヒト細胞傷害性Tリンパ球のエピトープ及びそのMUC−1の非VNTR(non−variablenumberoftandemrepeatsequence)由来のアゴニストエピトープ
TW201204410A (en) 2004-04-01 2012-02-01 Oncothyreon Inc Mucinous glycoprotein (MUC-1) vaccine
EP1812052A1 (en) * 2004-11-02 2007-08-01 Biomedical Research Models, Inc. Methods of cancer treatment/prevention using cancer cell-specific surface antigens
PT2366400E (pt) 2005-06-28 2016-02-02 Oncothyreon Inc Método de tratamento de doentes com uma vacina à base de glicoproteína mucinosa (muc-1)
WO2010002478A2 (en) 2008-07-03 2010-01-07 University Of Georgia Research Foundation, Inc. Glycopeptide and uses thereof
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
RU2377994C1 (ru) * 2008-05-21 2010-01-10 Леонид Валентинович Загребин Способ иммунореабилитации онкозаболеваний
US20100059084A1 (en) * 2008-09-10 2010-03-11 Austin American Technology Corporation Cleaning and testing ionic cleanliness of electronic assemblies
RU2578420C2 (ru) 2010-05-10 2016-03-27 Эсенд Байофармасьютикалз Пти Лтд Иммуностимулирующие и вакцинные композиции
JP2014518841A (ja) 2011-02-24 2014-08-07 オンコシレオン インク. アジュバントを備えたmuc1ベースのグリコリポペプチドワクチン
WO2013103658A1 (en) 2012-01-03 2013-07-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Native and agonist ctl epitopes of the muc1 tumor antigen
JP2016520073A (ja) 2013-05-14 2016-07-11 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Muc−1リポペプチドによるワクチン免疫で肺癌を治療する方法
WO2015058831A1 (en) 2013-10-25 2015-04-30 Merck Patent Gmbh Elevated biomarker expression in lung cancer patients responding to treatment with muc-1 lipopeptide vaccines
CN110325205B (zh) 2016-12-22 2023-08-15 库尔生物制药有限公司 T细胞调节性多聚体多肽及其使用方法
US11851471B2 (en) 2017-01-09 2023-12-26 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
KR20240005989A (ko) 2017-03-15 2024-01-12 큐 바이오파마, 인크. 면역 반응을 조절하는 방법
GB201812647D0 (en) 2018-08-03 2018-09-19 Chancellor Masters And Scholars Of The Univ Of Oxford Viral vectors and methods for the prevention or treatment of cancer
JP2022536581A (ja) * 2019-06-19 2022-08-18 キュー バイオファーマ, インコーポレイテッド 多量体t細胞調節性ポリペプチド及びその使用方法
IL296209A (en) 2020-05-12 2022-11-01 Cue Biopharma Inc Multimeric t-cell modulatory polypeptides and methods of using them
JP2023541366A (ja) 2020-09-09 2023-10-02 キュー バイオファーマ, インコーポレイテッド 1型真性糖尿病(t1d)を治療するためのmhcクラスii t細胞調節多量体ポリペプチド及びその使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2135068T3 (es) 1994-06-13 1999-10-16 Unilever Nv Activacion de blanqueantes.
DK0765386T3 (en) * 1994-06-14 2015-01-26 Univ Leland Stanford Junior Methods for T cell activation in vivo with antigen-incubated dendritic cells
AU5849796A (en) * 1994-12-27 1996-08-07 United Biomedical Inc. Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
AU6330896A (en) * 1995-06-07 1996-12-30 Governors Of The University Of Alberta, The A method for eliciting a th1-specific immune response
CA2282300C (en) 1997-02-24 2011-08-02 Therion Biologics Corporation Recombinant pox virus for immunization against muc1 tumor-associated antigen

Similar Documents

Publication Publication Date Title
JP2000509912A5 (cg-RX-API-DMAC10.html)
JP2000509635A5 (cg-RX-API-DMAC10.html)
JP2000507042A5 (cg-RX-API-DMAC10.html)
JP2000509637A5 (cg-RX-API-DMAC10.html)
JP2000510751A5 (cg-RX-API-DMAC10.html)
JP2000509942A5 (cg-RX-API-DMAC10.html)
JP2001511200A5 (cg-RX-API-DMAC10.html)
JP2001508161A5 (cg-RX-API-DMAC10.html)
JP2000509587A5 (cg-RX-API-DMAC10.html)
JP2000507369A5 (cg-RX-API-DMAC10.html)
JP2000507433A5 (cg-RX-API-DMAC10.html)
JP2000510793A5 (cg-RX-API-DMAC10.html)
JP2000508841A5 (cg-RX-API-DMAC10.html)
JP2001506183A5 (cg-RX-API-DMAC10.html)
JP2001513795A5 (cg-RX-API-DMAC10.html)
JP2000508680A5 (cg-RX-API-DMAC10.html)
JP2001518853A5 (cg-RX-API-DMAC10.html)
JP2000509804A5 (cg-RX-API-DMAC10.html)
JP2000509755A5 (cg-RX-API-DMAC10.html)
JP2000510969A5 (cg-RX-API-DMAC10.html)
JP2000510247A5 (cg-RX-API-DMAC10.html)
JP2002503221A5 (cg-RX-API-DMAC10.html)
JP2001511797A5 (cg-RX-API-DMAC10.html)
JP2000508102A5 (cg-RX-API-DMAC10.html)
JP2000509520A5 (cg-RX-API-DMAC10.html)